Bupivacaine
Sold as Bupivacaine HCL spinal ( ) fresenius, Pharma-q bupivacaine spinal with dextrose ( ), Pharma-q bupivacaine, Bupican, Bupivacaine HCL spinal with dextrose adco, Macaine viaflex, Bupivacaine viaflex adco, Macaine HCL, Macaine HCL spinal, Bupivacaine HCL ( ) fresenius, * adcane, Regibloc spinal m/v
1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
Drag to rotate. Structure from PubChem CID 2474.
Background
Registration
- Applicants
- 5
- Registrations
- 12
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Fresenius Kabi Manufacturing SA (Pty) Ltd | Bupivacaine HCL spinal ( ) fresenius, Bupivacaine HCL ( ) fresenius | 1 ml, 10 ml | 290558, W0335 | S4 | PIPIL |
| Pharma-q Holdings (Pty) Ltd | Pharma-q bupivacaine spinal with dextrose ( ), Pharma-q bupivacaine | 20 mg/4ml, 50 mg/10 ml | 310006, 310007 | Not determined | None |
| Biotech Laboratories (Pty) LtdCancelled | Bupican | Not stated | 450127 | Not determined | None |
| Adcock Ingram Critical Care (Pty) LtdCertificate held by Adcock Ingram Critical Care (Pty) Ltd. | Bupivacaine HCL spinal with dextrose adco, Macaine viaflex, Bupivacaine viaflex adco, Macaine HCL, Macaine HCL spinal, * adcane | 0,1 %, 0,5 %, 1 mL, 5 mg/mL | 510547, A400182, A400214, J0113, U0055, Z0063 | S4 | PIPIL |
| Bodene (Pty) Ltd Trading As IntramedCancelled | Regibloc spinal m/v | 0,75% | Z0095 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Bupivacaine HCL 0,5% spinal (4ml) fresenius EACH 4 ml SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE 20,0 mg | 1 mlSolution for injection. | 29055829/4/0558Approved 25 May 2023 | Registered | S4 | PIPIL |
| Pharma-q bupivacaine spinal with dextrose injection (20 mg/4ml) EACH 4 ml SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE 20 mg | 20 mg/4mlInjection | 31000631/4/0006 | Registered | Not determined | None |
| Pharma-q bupivacaine injection 50 mg/10 ML EACH 10 ml SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE 50 mg | 50 mg/10 mlInjection | 31000731/4/0007 | Registered | Not determined | None |
| Bupican EACH 1,0 ml SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE 5,0 mg | Not listed | 45012745/4/0127 | Cancelled | Not determined | None |
| Bupivacaine HCL 0,5 % spinal injection with dextrose adco EACH 4,0 ML CONTAINS: BUPIVACAINE HYDROCHLORIDE 20,0 mg | 5 mg/mLSpinal injection | 51054751/4/0547Approved 29 September 2025 | Registered | S4 | PIPIL |
| Macaine viaflex 0,1 % EACH 1000,0 ml SOLUTION CONTAINS BUPIVACAINE HYDROCHLORIDE 1,0 g | 0,1 % | A400182A40/4/0182 | Registered | Not determined | None |
| Bupivacaine 0,1 % viaflex adco EACH 1000,0 ml SOLUTION CONTAINS :BUPIVACAINE HYDROCHLORIDE 1,0 g | 0,1 % | A400214A40/4/0214 | Registered | Not determined | None |
| Macaine HCL 0,5 % injection EACH 1 ml SOLUTION CONTAINS: BUPIVACAINE HYDROCHLORIDE 5 mg | 1 mLInjection | J0113J/4/113Approved 27 October 2025 | Registered | S4 | PIPIL |
| Macaine HCL 0,5 % spinal injection EACH 1 ml SOLUTION CONTAINS :BUPIVACAINE HYDROCHLORIDE 5 mg | 0,5 %Injection | U0055U/4/55 | Registered | Not determined | None |
| Bupivacaine HCL 0,5% (10ml) fresenius EACH 10 ml INJECTION CONTAINS BUPIVACAINE HYDROCHLORIDE 50 mg | 10 mlSolution for injection. | W0335W/4/335Approved 17 September 2022 | Registered | S4 | PIPIL |
| * adcane EACH 10 ml SULUTION CONTAINS: BUPIVACAINE HYDROCHLORIDE 10 mg | Not listed | Z0063Z/4/63 | Registered | Not determined | None |
| Regibloc spinal 0,75% m/v injection EACH 2 ml AMPOULE CONTAINS BUPIVACAINE HYDROCHLORIDE 15 mg | 0,75%Injection | Z0095Z/4/95 | Cancelled | Not determined | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Bupivacaine HCL 0,5% spinal (4ml) fresenius, Fresenius Kabi Manufacturing SA (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.